OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $215,000 | -66.4% | 382,286 | +2.7% | 0.00% | -100.0% |
Q4 2015 | $640,000 | -18.4% | 372,324 | +0.2% | 0.00% | 0.0% |
Q3 2015 | $784,000 | -57.0% | 371,646 | +0.8% | 0.00% | -50.0% |
Q2 2015 | $1,825,000 | -34.8% | 368,690 | +3.1% | 0.00% | -50.0% |
Q1 2015 | $2,800,000 | +30.6% | 357,607 | +1.1% | 0.00% | +33.3% |
Q4 2014 | $2,144,000 | +40.3% | 353,763 | -1.4% | 0.00% | +50.0% |
Q3 2014 | $1,528,000 | -26.4% | 358,731 | +6.8% | 0.00% | -33.3% |
Q2 2014 | $2,075,000 | +3.9% | 335,836 | +9.3% | 0.00% | 0.0% |
Q1 2014 | $1,997,000 | +28.1% | 307,207 | +11.0% | 0.00% | +50.0% |
Q4 2013 | $1,559,000 | -5.5% | 276,862 | +2.9% | 0.00% | -33.3% |
Q3 2013 | $1,649,000 | +12.9% | 268,976 | +7.6% | 0.00% | 0.0% |
Q2 2013 | $1,461,000 | – | 249,948 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |